Dexmedetomidine in Children for Magnetic Resonance Imaging (MRI) Sedation

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Anesthesia
Interventions
DRUG

Dexmedetomidine

Drug: dexmedetomidine 100 mcg/mL was applied in 3 mcg/kg and 4 mcg/kg doses in 1 mL preperates, 0.5 mL for each nostril

All Listed Sponsors
lead

Sisli Hamidiye Etfal Training and Research Hospital

OTHER

NCT02299232 - Dexmedetomidine in Children for Magnetic Resonance Imaging (MRI) Sedation | Biotech Hunter | Biotech Hunter